161 related articles for article (PubMed ID: 14653429)
1. Pharmacologic management of psychosis in the elderly: a critical review.
Hoeh N; Gyulai L; Weintraub D; Streim J
J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):213-8. PubMed ID: 14653429
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics in Parkinson-sensitive populations.
Friedman JH; Fernandez HH
J Geriatr Psychiatry Neurol; 2002; 15(3):156-70. PubMed ID: 12230086
[TBL] [Abstract][Full Text] [Related]
3. Emergency treatment of acute psychosis.
Hillard JR
J Clin Psychiatry; 1998; 59 Suppl 1():57-60; discussion 61. PubMed ID: 9448670
[TBL] [Abstract][Full Text] [Related]
4. Review of recent clinical studies with olanzapine.
Tollefson GD; Kuntz AJ
Br J Psychiatry Suppl; 1999; (37):30-5. PubMed ID: 10211139
[TBL] [Abstract][Full Text] [Related]
5. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
[TBL] [Abstract][Full Text] [Related]
6. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
[TBL] [Abstract][Full Text] [Related]
7. Rationale and guidelines for the inpatient treatment of acute psychosis.
Feifel D
J Clin Psychiatry; 2000; 61 Suppl 14():27-32. PubMed ID: 11154014
[TBL] [Abstract][Full Text] [Related]
8. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic agents and bipolar disorder.
Tohen M; Zarate CA
J Clin Psychiatry; 1998; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
Marsh L; Lyketsos C; Reich SG
Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
[TBL] [Abstract][Full Text] [Related]
11. Management of psychotic aspects of Parkinson's disease.
Juncos JL
J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
Cummings JL; Street J; Masterman D; Clark WS
Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
[TBL] [Abstract][Full Text] [Related]
13. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
14. The management of psychosis in movement disorder patients.
Chou KL; Borek LL; Friedman JH
Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
[TBL] [Abstract][Full Text] [Related]
15. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine and negative symptoms.
Rosen EH
J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
[No Abstract] [Full Text] [Related]
17. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
19. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
Baskys A
J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
